Identification of potential prognostic biomarkers for hepatocellular carcinoma
Author(s) -
Lanyi Zhang,
Lingyi Yuan,
Dihua Li,
Miao Tian,
Siyu Sun,
Qi Wang
Publication year - 2022
Publication title -
journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.084
H-Index - 39
eISSN - 2219-679X
pISSN - 2078-6891
DOI - 10.21037/jgo-22-303
Subject(s) - kegg , hepatocellular carcinoma , gene , cancer research , cell cycle , cdc20 , computational biology , medicine , biology , bioinformatics , gene expression , genetics , transcriptome , anaphase
The incidence of liver cancer is increasing every year. Hepatocellular carcinoma (HCC) accounts for nearly 90% of liver cancer, and the overall 5-year survival rate of become of Hepatocellular carcinoma patients less than 20%. However, the molecular mechanism of HCC progression and prognosis still requires further exploration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom